Compare Zydus Wellness with GSK Consumer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS WELLNESS vs GSK CONSUMER - Comparison Results

GSK CONSUMER 
   Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS WELLNESS GSK CONSUMER ZYDUS WELLNESS/
GSK CONSUMER
 
P/E (TTM) x 36.9 39.1 94.4% View Chart
P/BV x 1.5 11.0 14.0% View Chart
Dividend Yield % 0.4 1.0 38.2%  

Financials

 ZYDUS WELLNESS   GSK CONSUMER
EQUITY SHARE DATA
    ZYDUS WELLNESS
Mar-19
GSK CONSUMER
Mar-19
ZYDUS WELLNESS/
GSK CONSUMER
5-Yr Chart
Click to enlarge
High Rs1,8307,819 23.4%   
Low Rs1,0855,832 18.6%   
Sales per share (Unadj.) Rs146.21,136.9 12.9%  
Earnings per share (Unadj.) Rs29.7233.7 12.7%  
Cash flow per share (Unadj.) Rs31.9248.1 12.8%  
Dividends per share (Unadj.) Rs5.00105.00 4.8%  
Dividend yield (eoy) %0.31.5 22.3%  
Book value per share (Unadj.) Rs587.3973.5 60.3%  
Shares outstanding (eoy) m57.6642.06 137.1%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.06.0 166.1%   
Avg P/E ratio x49.129.2 168.0%  
P/CF ratio (eoy) x45.727.5 166.2%  
Price / Book Value ratio x2.57.0 35.4%  
Dividend payout %16.844.9 37.5%   
Avg Mkt Cap Rs m84,039287,083 29.3%   
No. of employees `0000.23.8 5.5%   
Total wages/salary Rs m8566,446 13.3%   
Avg. sales/employee Rs Th39,755.712,440.2 319.6%   
Avg. wages/employee Rs Th4,037.71,677.0 240.8%   
Avg. net profit/employee Rs Th8,077.42,556.7 315.9%   
INCOME DATA
Net Sales Rs m8,42847,820 17.6%  
Other income Rs m3894,326 9.0%   
Total revenues Rs m8,81752,146 16.9%   
Gross profit Rs m1,74411,410 15.3%  
Depreciation Rs m125606 20.7%   
Interest Rs m3018 3,857.7%   
Profit before tax Rs m1,70615,123 11.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-65,295 -0.1%   
Profit after tax Rs m1,7129,828 17.4%  
Gross profit margin %20.723.9 86.7%  
Effective tax rate %-0.435.0 -1.0%   
Net profit margin %20.320.6 98.9%  
BALANCE SHEET DATA
Current assets Rs m6,98052,674 13.3%   
Current liabilities Rs m5,46318,140 30.1%   
Net working cap to sales %18.072.2 24.9%  
Current ratio x1.32.9 44.0%  
Inventory Days Days1,00936 2,841.0%  
Debtors Days Days4229 141.3%  
Net fixed assets Rs m45,7774,798 954.1%   
Share capital Rs m577421 137.1%   
"Free" reserves Rs m33,28640,527 82.1%   
Net worth Rs m33,86340,947 82.7%   
Long term debt Rs m15,0000-   
Total assets Rs m54,58560,681 90.0%  
Interest coverage x6.71,939.8 0.3%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.20.8 19.6%   
Return on assets %3.716.2 22.8%  
Return on equity %5.124.0 21.1%  
Return on capital %4.137.0 11.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m343,171 1.1%   
Fx outflow Rs m201,770 1.1%   
Net fx Rs m141,401 1.0%   
CASH FLOW
From Operations Rs m1,4946,711 22.3%  
From Investments Rs m-41,617-3,351 1,242.1%  
From Financial Activity Rs m40,515-3,768 -1,075.2%  
Net Cashflow Rs m1,086-408 -266.2%  

Share Holding

Indian Promoters % 72.5 0.0 -  
Foreign collaborators % 0.0 72.5 -  
Indian inst/Mut Fund % 7.9 0.8 987.5%  
FIIs % 7.9 12.0 65.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.7 14.8 79.1%  
Shareholders   37,518 26,457 141.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS WELLNESS With:   VADILAL INDUSTRIES  VST INDUSTRIES  SAVITA OIL  GOODRICKE  KAVERI SEED  

Compare ZYDUS WELLNESS With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

Sensex Tanks 661 Points; Banking and Finance Stocks Witness Huge Selling(Closing)

Indian share markets fell sharply today, led by weak Asian equities as worries of new lockdowns to stem surging coronavirus cases kept investors cautious worldwide.

Related Views on News

DR. LAL PATHLABS LTD at 52 Week High; BSE 500 Index Down 0.7 % (Market Updates)

Jul 14, 2020 | Updated on Jul 14, 2020

DR. LAL PATHLABS LTD share price has hit a 52-week high. It is presently trading at Rs 1,921. BSE 500 Index is down by 0.7% at 13,961. Within the BSE 500, DR. LAL PATHLABS LTD (up 1.8%) and GSK CONSUMER (up 5.1%) are among the top gainers, while top losers are SKF INDIA and BHEL.

DIXON TECHNOLOGIES at 52 Week High; BSE 500 Index Down 0.6 % (Market Updates)

Jul 14, 2020 | Updated on Jul 14, 2020

DIXON TECHNOLOGIES share price has hit a 52-week high. It is presently trading at Rs 6,500. BSE 500 Index is down by 0.6% at 13,961. Within the BSE 500, DIXON TECHNOLOGIES (up 0.5%) and GSK CONSUMER (up 5.1%) are among the top gainers, while top losers are SKF INDIA and YES BANK.

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

ZYDUS WELLNESS Announces Quarterly Results (3QFY20); Net Profit Down 89.5% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, ZYDUS WELLNESS has posted a net profit of Rs 42 m (down 89.5% YoY). Sales on the other hand came in at Rs 3 bn (up 128.8% YoY). Read on for a complete analysis of ZYDUS WELLNESS's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

These 3 Recent Events Will Impact the Price of Gold(Fast Profits Daily)

Jul 1, 2020

Recent developments in the bullion market may put some short term pressure on gold prices.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ZYDUS WELLNESS SHARE PRICE


Jul 14, 2020 (Close)

TRACK ZYDUS WELLNESS

  • Track your investment in ZYDUS WELLNESS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZYDUS WELLNESS

ZYDUS WELLNESS - RADICO KHAITAN COMPARISON

COMPARE ZYDUS WELLNESS WITH

MARKET STATS